QuickVue Dipstick Strep A Test, 50T, REF 20108, antigens, all groups, streptococcus spp.
Published May 20, 2026 · Recall initiated: April 6, 2026
Summary
FDA records medical device Class II recall Z-2169-2026, published May 20, 2026 and initiated April 6, 2026. Recalling firm: Quidel Corporation; Status: Ongoing; Reported quantity: 12279 units; Lot: UDI/DI 30014613201083, Lot Numbers: 225788, 228322, 233274. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Product has the potential for false positive results
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Quidel Corporation
- Distributor
- US Nationwide distribution in the states of AL, CA, FL, ID, IL, LA, MA, MD, MN, MO, NY, PA, SC, TN, TX, VA.
- Lot
- UDI/DI 30014613201083, Lot Numbers: 225788, 228322, 233274.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDA3DIMENSIONS MAMMOGRAPHY SYSTEM; Model Numbers: 3DM-SYS-INTL2D, 3DM-SYS-INTL2D-MOB, 3DM-SYS-INTL2D-NS,May 20, 2026
- FDAPhilips Azurion. System Code Description (Model Number): Azurion 3 M12 (722221, 722229), Azurion 3 M15May 20, 2026
- FDAQUIDEL InflammaDry MMP-9 Test, REF: PRS-ID-20, 20 TestsMay 1, 2024
- FDAQUIDEL InflammaDry MMP-9 Test, REF: PRS-ID-20-U, 20 TestsMay 1, 2024
- FDAThe Sofia 2 Flu + SARS Antigen FIA employs immunofluorescence technology in a sandwich design that is usedFebruary 21, 2024
- FDAInflammaDry(R) AN RPS DIAGNOSTIC SOLUTION, Sample Collectors InflammaDry(R) is a rapid, immunoassay test forAugust 9, 2017
Questions about this recall
Was QuickVue Dipstick Strep A Test, 50T, REF 20108, antigens, all groups, streptococcus spp. recalled?
Yes. FDA published recall Z-2169-2026 on May 20, 2026. Reported hazard: Product has the potential for false positive results
What should I do if I have this product?
Voluntary: Firm initiated · Letter